Factors Associated with Adherence to and Treatment Duration of Erlotinib Among Patients with Non-Small Cell Lung Cancer. [electronic resource]
Producer: 20180307Description: 643-652 p. digitalISSN:- 2376-1032
- Aged
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Erlotinib Hydrochloride -- economics
- Female
- Health Care Costs
- Health Expenditures
- Humans
- Insurance Claim Review -- economics
- Longitudinal Studies
- Lung Neoplasms -- drug therapy
- Male
- Medicaid -- economics
- Medicare -- economics
- Retrospective Studies
- United States
- Assessment of Medication Adherence
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.